Issue Date: October 29, 2007
Ranbaxy To Spin Off Drug Discovery Arm
Ranbaxy Laboratories has taken the first steps to spinning off its drug discovery unit. The Indian company says establishing independence for the R&D unit will provide the flexibility needed to accelerate development of its drug pipeline. Ranbaxy is one of a number of Indian companies previously focused on generic drugs or contract research that have forged into internal drug discovery. This summer, Nicholas Piramal India revealed plans to create a separate R&D unit.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society